Articles tagged with: Reproductive Health

Apr19

IF YOU LIKE IT, PUT A RING IN IT! THE INTRAVAGINAL RING THAT MAY SOON BE A LIFE CHANGER IN THE SEXUAL AND REPRODUCTIVE HEALTH ARENA

Thursday, 19 April 2018 Written by // Everlyne Ombati, MSc Tags // Contraception, End-User, HIV, Reproductive Health, STIs, Vaginal Ring

Yes! Yes! We soon may have a ring for our vaginas! I know what you are thinking; vaginal rings have been here since sliced bread. True, but what’s new about this one is that it will provide protection from HIV. Future rings will also include protection from unintended pregnancies and other sexually transmitted infections (STIs), too. And when that ring is available, I am putting it in! Because I like my vagina, and I want to stay healthy.

Apr03

From the Pipeline | WHY WOMEN-CENTERED MPT DEVELOPMENT MATTERS

Tuesday, 03 April 2018 Written by // Martha Brady, Maggie Kilbourne-Brook Series // From the Pipeline Tags // Contraception, End-User, HIV, Pipeline, Reproductive Health, STIs

Incorporating what women want into new sexual and reproductive health products is essential

We at PATH make it our business to reflect on the elusive topic of ‘what women want’—in terms of protection options in their sexual and reproductive lives. Not surprisingly, the answer is complex. Women want and need different things at different stages of their lifecycle, depending on the circumstances of their lives.

Mar13

From the Pipeline | A LONG-ACTING MULTIPURPOSE PREVENTION RING TO HELP PROTECT AGAINST HIV AND UNINTENDED PREGNANCY

Tuesday, 13 March 2018 Written by // Crystal Ng, MPH Series // From the Pipeline Tags // Contraception, End-User, HIV, Pipeline, Reproductive Health, Vaginal Ring, Women

Leveraging its experience developing the first vaginal ring and long-acting product shown to help prevent HIV, the nonprofit International Partnership for Microbicides is now developing a three-month vaginal ring designed to reduce women’s HIV risk and prevent unplanned pregnancy. This innovative multipurpose prevention technology would offer women a discreet option to protect their sexual and reproductive health on their own terms.

Feb26

From the Pipeline | THE ROAD TO FEMALE CONTROLLED PREVENTION: THE FEMALE CONDOM AS A CURRENTLY AVAILABLE MPT

Monday, 26 February 2018 Written by // Denise Van Dijk Series // From the Pipeline Tags // Contraception, End-User, Female Condom, HIV, Pipeline, Product, Reproductive Health, STIs

The Road

6 years; 12 Million Dollars.

When the founders of the Female Health Company (FHC) began conceptualizing the female condom in 1996, they wanted to create a product that would impact society as well as benefit investors. Little did they know that it would be a long road to develop a market for the female condom.

Dec21

ICYMI: DISCUSSION ON END-USER RESEARCH FOR MPT R&D

Thursday, 21 December 2017 Tags // Contraception, End-User, HIV, Product, Reproductive Health, Research

At this point, we do not likely need to convince you that if you are aiming to develop and introduce an MPT product, incorporating end-user research into the process is a good idea, especially if you want it to have a positive public health impact. We at the IMPT Secretariat are delighted that end-user research has become an increased focus in the contraception, HIV prevention, and global health spaces. It is now critical that enthusiasm for end-user research in these fields is applied effectively – that is, employs the right methods with the right stakeholders during the right stages, asks questions that fill knowledge gaps rather than ‘reinvent the wheel,’ and otherwise addresses past challenges experienced with this type of research.

[12  >>  

Share

Spread the word about the promise of MPTs.

Collaborate

We will go further together – join the movement for MPTs.

Contribute

Your financial and in-kind support can help make MPTs a reality.